CAPGEMINI news, videos and press releases - Page 3
For more news please use our advanced search feature.
CAPGEMINI - More news...
CAPGEMINI - More news...
-
FINTECH NEWS: Gemini Secures $400M, MoonPay Rides The Crypto Wave
- Capgemini SE: Success of the 8th Employee Share Ownership Plan
- Mogo Adds to Strategic Investment Portfolio with Minority Investment in Gemini
- Capgemini to Add 1,500 Jobs in the U.S. with Launch of Nashville Delivery Center and Expansion of Columbia and Houston Sites
- Gemini Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
- Gemini Therapeutics Announces Poster Presentation at AAO 2021
- Gemini Therapeutics to Participate in Upcoming Investor Conferences
- Capgemini Press release// Capgemini raises all its 2021 financial targets after an excellent third quarter
- Gemini Therapeutics Announces Presentation at 2nd Annual Dry AMD Therapeutic Development Summit
- Gemini Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Gemini Therapeutics Announces Corporate Restructuring to Prioritize Late-Stage Clinical Development of GEM103 for Geographic Atrophy
- Capgemini Named a Leader in the US ISG Provider Lens™ Retail Software and Services Report
- Command The 5G Network: VIAVI and Capgemini Collaborate on 5G and O-RAN Validation
- Capgemini press release// Capgemini signs agreement to acquire IT services provider VariQ, adding scalability and strengths to its Government Solutions capabilities in the U.S.
- Avasant Names Capgemini a Leader in US Aerospace and Defense Digital Services
- Gemini Therapeutics Announces Presentation of Preclinical Data at the 13th International Conference on Complement Therapeutics
- Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at EURETINA 2021 Virtual
- Gemini Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
- Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at Clinical Trials at the Summit
- Gemini Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
- Gemini Therapeutics to Participate in the H.C. Wainwright Ophthalmology Conference
- Capgemini SE: Availability of the First Half 2021 Financial Report
- Emergency Medical Products Chooses Capgemini to Drive Digital Transformation Initiative
- Gemini Therapeutics Announces Initial Data From Its Ongoing Phase 2a Study of GEM103 in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
- Gemini Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
- Maxeon Solar Technologies to Supply High-Efficiency Solar Panels for Primergy's GW-Scale Gemini Project
- Gemini Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
- Gemini Therapeutics Completes Enrollment in Phase 2a Study of GEM103 as an Add-On to Anti-VEGF Therapy for the Treatment of Wet AMD Patients at Risk for Progressive Vision Loss Due to Macular Atrophy
- Resorts World Las Vegas Announces Partnership With Cryptocurrency Exchange Gemini
- Gemini Therapeutics Announces Appointment of Georges Gemayel, Ph.D. as Chair of Board of Directors
